Search research articles
Contact Us
Filters
Showing results (271-280 of 366) with videos related to
Page
of 37
Sort By:
Blood
|
January 1, 1984
Primary therapy of acute promyelocytic leukemia: results of amsacrine- and daunorubicin-based therapy
Z Arlin, S Kempin, R Mertelsmann, et al.
Cancer
|
August 15, 1980
Analysis of multiple cell markers in acute leukemia complicating Hodgkin's disease
S C Gulati, R Mertelsmann, T Gee, et al.
Blood
|
July 15, 1992
Expression of bcl-2 in Burkitt's lymphoma cell lines: induction by latent Epstein-Barr virus genes
J Finke, R Fritzen, P Ternes, et al.
Blood
|
August 1, 1996
Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines
R M Weber-Nordt, C Egen, J Wehinger, et al.
British Journal of Haematology
|
July 1, 1993
Peripheral blood progenitor cells mobilized by chemotherapy plus granulocyte-colony stimulating factor accelerate both neutrophil and platelet recovery after high-dose VP16, ifosfamide and cisplatin
W Brugger, R Birken, H Bertz, et al.
Journal of Cancer Research and Clinical Oncology
|
January 1, 1980
A micromethod for determination of terminal deoxynucleotidyl transferase (TdT) in the diagnostic evaluation of acute leukemias
M J Modak, R Mertelsmann, B Koziner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 1, 1997
The transjugular stent implantation for the treatment of malignant portal and hepatic vein obstruction in cancer patients
J A Burger, A Ochs, K Wirth, et al.
Blut
|
February 1, 1990
Erythropoietin prevents chemotherapy-induced anemia: case report
W Oster, F Herrmann, A Cicco, et al.
Blood
|
March 1, 1988
Randomized study of 13-cis retinoic acid v placebo in the myelodysplastic disorders
H P Koeffler, D Heitjan, R Mertelsmann, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
April 1, 1994
Serum cytokine levels in cancer patients treated with different schedules of ultra-low-dose interleukin-2
A Lindemann, P Brossart, K Höffken, et al.
Page
of 37
Search research articles
Search
Showing results (271-280 of 366) with videos related to
Sort By:
Page
of 37
Blood
|
January 1, 1984
Primary therapy of acute promyelocytic leukemia: results of amsacrine- and daunorubicin-based therapy
Z Arlin, S Kempin, R Mertelsmann, et al.
Cancer
|
August 15, 1980
Analysis of multiple cell markers in acute leukemia complicating Hodgkin's disease
S C Gulati, R Mertelsmann, T Gee, et al.
Blood
|
July 15, 1992
Expression of bcl-2 in Burkitt's lymphoma cell lines: induction by latent Epstein-Barr virus genes
J Finke, R Fritzen, P Ternes, et al.
Blood
|
August 1, 1996
Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines
R M Weber-Nordt, C Egen, J Wehinger, et al.
British Journal of Haematology
|
July 1, 1993
Peripheral blood progenitor cells mobilized by chemotherapy plus granulocyte-colony stimulating factor accelerate both neutrophil and platelet recovery after high-dose VP16, ifosfamide and cisplatin
W Brugger, R Birken, H Bertz, et al.
Journal of Cancer Research and Clinical Oncology
|
January 1, 1980
A micromethod for determination of terminal deoxynucleotidyl transferase (TdT) in the diagnostic evaluation of acute leukemias
M J Modak, R Mertelsmann, B Koziner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 1, 1997
The transjugular stent implantation for the treatment of malignant portal and hepatic vein obstruction in cancer patients
J A Burger, A Ochs, K Wirth, et al.
Blut
|
February 1, 1990
Erythropoietin prevents chemotherapy-induced anemia: case report
W Oster, F Herrmann, A Cicco, et al.
Blood
|
March 1, 1988
Randomized study of 13-cis retinoic acid v placebo in the myelodysplastic disorders
H P Koeffler, D Heitjan, R Mertelsmann, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
April 1, 1994
Serum cytokine levels in cancer patients treated with different schedules of ultra-low-dose interleukin-2
A Lindemann, P Brossart, K Höffken, et al.
Page
of 37